A newly developed antibiotic, EVG7, is showing promising results in the fight against Clostridioides difficile (C. Difficile), a dangerous bacterium that causes severe intestinal infections, particularly in vulnerable populations. Researchers at Leiden University in the Netherlands have demonstrated that a low dose of EVG7 effectively clears the infection in mice and significantly reduces the likelihood … Read more